- Home
- SEPN vs AWP Comparison
SEPN vs AWP Comparison
Compare SEPN & AWP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEPN
- AWP
- Stock Information
- Founded
- SEPN 2022
- AWP 2007
- Country
- SEPN United States
- AWP United States
- Employees
- SEPN N/A
- AWP N/A
- Industry
- SEPN
- AWP Trusts Except Educational Religious and Charitable
- Sector
- SEPN
- AWP Finance
- Exchange
- SEPN NYSE
- AWP Nasdaq
- Market Cap
- SEPN 311.6M
- AWP 331.0M
- IPO Year
- SEPN 2024
- AWP N/A
- Fundamental
- Price
- SEPN $6.69
- AWP $3.91
- Analyst Decision
- SEPN Buy
- AWP
- Analyst Count
- SEPN 4
- AWP 0
- Target Price
- SEPN $33.00
- AWP N/A
- AVG Volume (30 Days)
- SEPN 181.2K
- AWP 331.5K
- Earning Date
- SEPN 05-19-2025
- AWP 01-01-0001
- Dividend Yield
- SEPN N/A
- AWP 12.48%
- EPS Growth
- SEPN N/A
- AWP N/A
- EPS
- SEPN N/A
- AWP N/A
- Revenue
- SEPN $1,075,000.00
- AWP N/A
- Revenue This Year
- SEPN N/A
- AWP N/A
- Revenue Next Year
- SEPN N/A
- AWP N/A
- P/E Ratio
- SEPN N/A
- AWP N/A
- Revenue Growth
- SEPN 611.92
- AWP N/A
- 52 Week Low
- SEPN $4.17
- AWP $3.06
- 52 Week High
- SEPN $28.99
- AWP $4.20
- Technical
- Relative Strength Index (RSI)
- SEPN N/A
- AWP 57.18
- Support Level
- SEPN N/A
- AWP $3.90
- Resistance Level
- SEPN N/A
- AWP $3.95
- Average True Range (ATR)
- SEPN 0.00
- AWP 0.06
- MACD
- SEPN 0.00
- AWP 0.02
- Stochastic Oscillator
- SEPN 0.00
- AWP 70.83
About SEPN SEPTERNA INC
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.
About AWP abrdn Global Premier Properties Fund of Beneficial Interest
Aberdeen Global Premier Properties Fund is a diversified, closed-end management investment company. Its objective is to seek high current income and capital appreciation. It predominantly invests in equity and debt securities of domestic and foreign issuers which are principally engaged in the real estate industry, real estate financing or control real estate assets. Its portfolio of investments consists securities of Industrial REITs, Retail REITs, Data Center REITs, Health Care REITs and others.